Hikma Pharmaceuticals PLC (LON:HIK – Get Free Report)’s share price crossed above its 200-day moving average during trading on Friday . The stock has a 200-day moving average of GBX 1,928.90 ($23.47) and traded as high as GBX 2,102 ($25.57). Hikma Pharmaceuticals shares last traded at GBX 2,091.92 ($25.45), with a volume of 345,375 shares.
Hikma Pharmaceuticals Trading Up 1.0 %
The firm has a market cap of £4.64 billion, a P/E ratio of 3,218.34, a P/E/G ratio of 2.38 and a beta of 0.41. The company has a debt-to-equity ratio of 55.48, a quick ratio of 1.27 and a current ratio of 1.66. The firm has a fifty day moving average of GBX 1,949.17 and a 200-day moving average of GBX 1,928.90.
About Hikma Pharmaceuticals
At Hikma we help put better health within reach, every day. By creating high-quality medicines and making them accessible to the people who need them, we help to shape a healthier world that enriches all our communities. We help deliver this by living our culture, delivering our strategy, and acting responsibly.
Recommended Stories
- Five stocks we like better than Hikma Pharmaceuticals
- How to Calculate Options Profits
- Earn High Dividends With 2 Top REITs Set to Perform in 2025
- 3 Must-Buy Warren Buffett Stocks for Volatile Times
- Oilfield Leader SLB: An AI Name You Need to Know
- Industrial Products Stocks Investing
- Top ETFs That Beat the Market in 2024 and Could Do It Again
Receive News & Ratings for Hikma Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hikma Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.